DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 011909
» See Plans and Pricing
NDA 011909 describes NARDIL, which is a drug marketed by Parke Davis and is included in one NDA. Additional details are available on the NARDIL profile page.
The generic ingredient in NARDIL is phenelzine sulfate. There are four drug master file entries for this compound. Additional details are available on the phenelzine sulfate profile page.
The generic ingredient in NARDIL is phenelzine sulfate. There are four drug master file entries for this compound. Additional details are available on the phenelzine sulfate profile page.
Summary for 011909
| Tradename: | NARDIL |
| Applicant: | Parke Davis |
| Ingredient: | phenelzine sulfate |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 011909
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 15MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | Yes | ||||
Complete Access Available with Subscription
